The shorts are so desperate, notice ALL they can post is BS. Right now, and can be confirmed by visit to Geron site. Geron.com Phase II trials underway. They were expanded, look very positive and in many locations. All one has to do is confirm the facts folks. From their site: and think about the implications. They are going after MAJOR markets in Cancer.
Telomerase Inhibitor Drug - Imetelstat (GRN163L)
Randomized Phase 2 clinical trials:
· Non-small cell lung cancer (NSCLC). Click for more information.
· Breast cancer. Click for more information.
Single arm Phase 2 clinical trials:
· Multiple myeloma. Click for more information.
· Essential thrombocythemia. Click for more information.
A complete list of clinical trials of imetelstat, including participating sites and contact information, is available at the U.S. National Library of Medicine website at www.clinicaltrials.gov (please search " imetelstat").